Return to search results
💡 Advanced Search Tip
Search by organization or tag to find related datasets
Patent AT-E400274-T1: [Translated] ACT ACTIVITY INHIBITORS
The present invention is directed to compounds comprising a 2,3-diphenylquinoxaline moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention
Complete Metadata
| bureauCode |
[ "009:25" ] |
|---|---|
| identifier | https://healthdata.gov/api/views/nfqi-ces2 |
| issued | 2025-09-05 |
| landingPage | https://healthdata.gov/d/nfqi-ces2 |
| programCode |
[ "009:066" ] |
| theme |
[ "NIH" ] |
